Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jul 5;31(7):1865-1867.
doi: 10.1016/j.ymthe.2023.04.014. Epub 2023 May 17.

Always a bridesmaid, never a bride: Committing to flu neuraminidase as a vaccine target

Affiliations
Comment

Always a bridesmaid, never a bride: Committing to flu neuraminidase as a vaccine target

Cosette Schneider et al. Mol Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of interests The authors do not have any interests to disclose.

Figures

Figure 1
Figure 1
Mechanisms of action of NA-specific antibodies (A) Current influenza virus vaccine development is focused on trimeric hemagglutinin (HA), the major viral surface glycoprotein important for virus binding to the viral entry receptor, sialic acid (SA). However, tetrameric neuraminidase (NA), the second viral surface glycoprotein, important for releasing virus from SA through its sialidase activity, is reemerging as a potential target. (B) Anti-NA Abs act to antagonize the virus by (1) blocking NA-mediated enzymatic cleavage of virus from mucins in the airway, (2) indirectly blocking HA binding to SA through steric hindrance, (3) acting synergistically with HA stalk Abs to activate FcγR effector functions, such as antibody-dependent cellular cytotoxicity (ADCC), and (4) blocking NA enzymatic activity at the point of viral egress to prevent cleavage of viral aggregates or inhibit viral release and onward spread within the host. Figure created with BioRender.com.
Figure 2
Figure 2
Novel dimeric NA-based APC-targeting DNA vaccine elicits protective anti-NA antibodies in vivo Vaccine DNA plasmids were engineered as three-component fusion constructs encoding (1) an APC-targeting unit (svFv-MHC II), (2) a dimerization unit containing either the acid or base (A/B) component of a modified Jun/Fos leucine zipper motif, and (3) a dimeric antigen unit encoding the ectodomain of N1 from H1N1 virus A/Puerto Rico/8/34/Mount Sinai. Following immunization of mice, in vivo expression and dimerization of A/B-fused NA targeted to MHC II resulted in the induction of NA-based, Ab-mediated protection against homologous virus through a mechanism considered to enhance B cell receptor (BCR) cross-linking. Figure created with BioRender.com.

Comment on

Similar articles

Cited by

References

    1. Kerstetter L.J., Buckley S., Bliss C.M., Coughlan L. Adenoviral vectors as vaccines for emerging avian influenza viruses. Front. Immunol. 2020;11 doi: 10.3389/fimmu.2020.607333. - DOI - PMC - PubMed
    1. Coughlan L., Palese P. Overcoming barriers in the path to a universal influenza virus vaccine. Cell Host Microbe. 2018;24:18–24. doi: 10.1016/j.chom.2018.06.016. - DOI - PubMed
    1. Werninghaus I.C., Hinke D.M., Fossum E., Bogen B., Braathen R. Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza. Mol. Ther. 2023 doi: 10.1016/j.ymthe.2023.03.012. - DOI - PMC - PubMed
    1. Hinke D.M., Andersen T.K., Gopalakrishnan R.P., Skullerud L.M., Werninghaus I.C., Grødeland G., Fossum E., Braathen R., Bogen B. Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses. Cell Rep. 2022;39 doi: 10.1016/j.celrep.2022.110901. - DOI - PubMed
    1. Wohlbold T.J., Krammer F. In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen. Viruses. 2014;6:2465–2494. doi: 10.3390/v6062465. - DOI - PMC - PubMed

Publication types